| BRIUMVI TG Therapeutics, Inc.
90760688 08 Jun 2021 | on 11 Apr 2023
| Pharmaceutical preparations for human use, namely, pharmaceutical prep... Class 005 Class 005 Pharmaceutical Products The wording BRIUMVI has no meaning in a foreign language. | | | BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV TG Therapeutics, Inc.
98433749 05 Mar 2024 | on 10 Dec 2024 | Providing health information Class 044 Class 044 Medical, Beauty & Agricultural Services The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue sphere edged in gold. | | | BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV TG Therapeutics, Inc.
98433740 05 Mar 2024 | on 10 Dec 2024 | Providing health information Class 044 Class 044 Medical, Beauty & Agricultural Services The mark consists of the text "BRIUMVI" above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" with the "B" in "BRIUMVI" partially surrounded by a sphere edged by a circular line. | | | BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV TG THERAPEUTICS, INC.
97715586 13 Dec 2022 | on 03 Dec 2024 | pharmaceutical preparations for human use, namely, pharmaceutical prep... Class 005 Class 005 Pharmaceutical Products The mark consists of the text "BRIUMVI" above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" with the "B" in "BRIUMVI" partially surrounded by a sphere edged by a circular line; the colors grey and white represent shaded and transparent areas and are not claimed as a feature of the mark. | | | BRIUMVI UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV TG THERAPEUTICS, INC.
97715574 13 Dec 2022 | on 03 Dec 2024 | pharmaceutical preparations for human use, namely, pharmaceutical prep... Class 005 Class 005 Pharmaceutical Products The mark consists of the text "BRIUMVI" in black above the text "UBLITUXIMAB-XIIY 150 MG/6ML INJECTION FOR IV" in dark grey with the "B" in "BRIUMVI" partially surrounded by a light blue sphere edged in gold. | | | UBLYX TG THERAPEUTICS, INC.
97418587 19 May 2022 | on 29 Nov 2024 | pharmaceutical preparations and substances for the treatment of oncolo... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations and substances for the treatment of oncological, autoimmune and central nervous system diseases and disorders | | | UBLYXI TG THERAPEUTICS, INC.
97418579 19 May 2022 | on 29 Nov 2024 | pharmaceutical preparations and substances for the treatment of oncolo... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations and substances for the treatment of oncological, autoimmune and central nervous system diseases and disorders | | | UBLI TG THERAPEUTICS, INC.
97418597 19 May 2022 | on 29 Nov 2024 | pharmaceutical preparations and substances for the treatment of oncolo... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations and substances for the treatment of oncological, autoimmune and central nervous system diseases and disorders | | | UBLIXI TG THERAPEUTICS, INC.
97418589 19 May 2022 | on 29 Nov 2024 | pharmaceutical preparations and substances for the treatment of oncolo... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations and substances for the treatment of oncological, autoimmune and central nervous system diseases and disorders | | | JUBIDEP TG Therapeutics, Inc.
90850121 27 Jul 2021 | on 01 Jan 2024 | pharmaceutical preparations for human use, namely, pharmaceutical prep... Class 005 Class 005 Pharmaceutical Products The wording JUBIDEP has no meaning in a foreign language. | | 
